Infusion Pumps and Accessories Market

Executive Summary

Infusion Pumps and Accessories Market was valued at US $14,044.60 million in 2021 and is projected to grow at 9.50% CAGR over the forecast period to reach US $24,212.38 million by 2027. Infusion Pumps and Accessories Market represented US $2,331.64 million opportunity over 2019-2021 and estimated to create US $10,167.79 million opportunity in 2027 over 2021.

Infusion Pumps and Accessories from Consainsights analyses the Infusion Pumps and Accessories Market in the Life Sciences industry over the forecast period to 2027.

Infusion Pumps and Accessories research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Infusion Pumps and Accessories segmentation includes Product Type, Application, End User and Geography.

Based on the Product Type, the Infusion Pumps and Accessories analysis covers Infusion Pump Types, Accessories/Disposables.

In Product Type segment, Infusion Pump Types segment has highest cagr growth of 8.40%.

Based on the Application, the Infusion Pumps and Accessories analysis covers Gastroenterology, Diabetes Management, Hematology, Other Applications.

In Application segment, Gastroenterology segment has highest cagr growth of 8.40%.

Based on the End User, the Infusion Pumps and Accessories analysis covers Hospitals, Ambulatory Surgery Center, Other End Users.

In End User segment, Hospitals segment has highest cagr growth of 8.40%.

Based on the region, the Infusion Pumps and Accessories analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Baxter International Inc., Becton, Dickinson and Company, Braun Melsungen AG, CareFusion Corporation, Eli Lilly and Company, F. Hoffmann-la Roche Ltd, Fresenius Kabi, ICU Medical Inc., Johnson & Johnson, Medtronic Inc., Nipro Corporation, Option Care Health Inc., Pfizer Inc., Smiths Medical, Terumo Corporation and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product Type

Introduction

In 2021, Infusion Pump Types segment has the highest revenue of US $7,326.76 million and is expected to grow at CAGR of 8.40% by 2027 Infusion Pump Types segment has highest cagr growth of 8.40%.

Infusion Pump Types

Infusion Pump Types segment was valued at US $6,110.39 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $12,631.07 million by 2027. Infusion Pump Types segment represented US $1,216.37 million opportunity over 2019-2021 and estimated to create US $5,304.31 million opportunity in 2027 over 2021.

Accessories/Disposables

Accessories/Disposables segment was valued at US $5,602.56 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $11,581.31 million by 2027. Accessories/Disposables segment represented US $1,115.27 million opportunity over 2019-2021 and estimated to create US $4,863.48 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Gastroenterology segment has the highest revenue of US $6,125.24 million and is expected to grow at CAGR of 8.40% by 2027 Gastroenterology segment has highest cagr growth of 8.40%.

Gastroenterology

Gastroenterology segment was valued at US $5,108.34 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $10,559.69 million by 2027. Gastroenterology segment represented US $1,016.89 million opportunity over 2019-2021 and estimated to create US $4,434.45 million opportunity in 2027 over 2021.

Diabetes Management

Diabetes Management segment was valued at US $2,877.10 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $5,947.38 million by 2027. Diabetes Management segment represented US $572.73 million opportunity over 2019-2021 and estimated to create US $2,497.55 million opportunity in 2027 over 2021.

Hematology

Hematology segment was valued at US $3,566.48 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $7,372.44 million by 2027. Hematology segment represented US $709.96 million opportunity over 2019-2021 and estimated to create US $3,096.00 million opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $161.03 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $332.87 million by 2027. Other Applications segment represented US $32.06 million opportunity over 2019-2021 and estimated to create US $139.79 million opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $8,006.91 million and is expected to grow at CAGR of 8.40% by 2027 Hospitals segment has highest cagr growth of 8.40%.

Hospitals

Hospitals segment was valued at US $6,677.63 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $13,803.63 million by 2027. Hospitals segment represented US $1,329.28 million opportunity over 2019-2021 and estimated to create US $5,796.72 million opportunity in 2027 over 2021.

Ambulatory Surgery Center

Ambulatory Surgery Center segment was valued at US $4,892.05 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $10,112.58 million by 2027. Ambulatory Surgery Center segment represented US $973.84 million opportunity over 2019-2021 and estimated to create US $4,246.69 million opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $143.28 million in 2019 and is projected to grow at 8.40% CAGR over the forecast period to reach US $296.18 million by 2027. Other End Users segment represented US $28.52 million opportunity over 2019-2021 and estimated to create US $124.38 million opportunity in 2027 over 2021.